Cargando…

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers

SIMPLE SUMMARY: Cancer ranks as a leading cause of death worldwide, which is often the result of recurrence and metastasis. Surgical resection is the mainstay of cancer treatment for potentially removable solid tumors. However, surgery-induced stress responses may lead to immunosuppression and subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Wei-Cheng, Lai, Hou-Chuan, Huang, Yi-Hsuan, Chan, Shun-Ming, Wu, Zhi-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913216/
https://www.ncbi.nlm.nih.gov/pubmed/36765695
http://dx.doi.org/10.3390/cancers15030739
_version_ 1784885371502329856
author Tseng, Wei-Cheng
Lai, Hou-Chuan
Huang, Yi-Hsuan
Chan, Shun-Ming
Wu, Zhi-Fu
author_facet Tseng, Wei-Cheng
Lai, Hou-Chuan
Huang, Yi-Hsuan
Chan, Shun-Ming
Wu, Zhi-Fu
author_sort Tseng, Wei-Cheng
collection PubMed
description SIMPLE SUMMARY: Cancer ranks as a leading cause of death worldwide, which is often the result of recurrence and metastasis. Surgical resection is the mainstay of cancer treatment for potentially removable solid tumors. However, surgery-induced stress responses may lead to immunosuppression and subsequent cancer regrowth and spread. Evidence shows that the tumor microenvironment plays an essential role in disease progression through mechanisms such as inflammation promotion. Tumor necrosis factor alpha (TNF-α) is one of the pro-inflammatory cytokines found in cancer patients and is reported to be involved in the immune system as well as in the surveillance of tumor growth. To date, several studies have demonstrated that various anesthetic agents or techniques and perioperative management have varying effects on innate and cellular immunity, the enhancement of adrenergic-inflammatory responses, and the activation of cancer-promoting cellular signaling pathways, which may be associated with long-term cancer outcomes. This review outlines the current knowledge of anesthesia implications on TNF-α release and provides potential anesthetic strategies for improving patient survival. ABSTRACT: Cancer remains a major public health issue and a leading cause of death worldwide. Despite advancements in chemotherapy, radiation therapy, and immunotherapy, surgery is the mainstay of cancer treatment for solid tumors. However, tumor cells are known to disseminate into the vascular and lymphatic systems during surgical manipulation. Additionally, surgery-induced stress responses can produce an immunosuppressive environment that is favorable for cancer relapse. Up to 90% of cancer-related deaths are the result of metastatic disease after surgical resection. Emerging evidence shows that the interactions between tumor cells and the tumor microenvironment (TME) not only play decisive roles in tumor initiation, progression, and metastasis but also have profound effects on therapeutic efficacy. Tumor necrosis factor alpha (TNF-α), a pleiotropic cytokine contributing to both physiological and pathological processes, is one of the main mediators of inflammation-associated carcinogenesis in the TME. Because TNF-α signaling may modulate the course of cancer, it can be therapeutically targeted to ameliorate clinical outcomes. As the incidence of cancer continues to grow, approximately 80% of cancer patients require anesthesia during cancer care for diagnostic, therapeutic, or palliative procedures, and over 60% of cancer patients receive anesthesia for primary surgical resection. Numerous studies have demonstrated that perioperative management, including surgical manipulation, anesthetics/analgesics, and other supportive care, may alter the TME and cancer progression by affecting inflammatory or immune responses during cancer surgery, but the literature about the impact of anesthesia on the TNF-α production and cancer progression is limited. Therefore, this review summarizes the current knowledge of the implications of anesthesia on cancers from the insights of TNF-α release and provides future anesthetic strategies for improving oncological survival.
format Online
Article
Text
id pubmed-9913216
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99132162023-02-11 Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers Tseng, Wei-Cheng Lai, Hou-Chuan Huang, Yi-Hsuan Chan, Shun-Ming Wu, Zhi-Fu Cancers (Basel) Review SIMPLE SUMMARY: Cancer ranks as a leading cause of death worldwide, which is often the result of recurrence and metastasis. Surgical resection is the mainstay of cancer treatment for potentially removable solid tumors. However, surgery-induced stress responses may lead to immunosuppression and subsequent cancer regrowth and spread. Evidence shows that the tumor microenvironment plays an essential role in disease progression through mechanisms such as inflammation promotion. Tumor necrosis factor alpha (TNF-α) is one of the pro-inflammatory cytokines found in cancer patients and is reported to be involved in the immune system as well as in the surveillance of tumor growth. To date, several studies have demonstrated that various anesthetic agents or techniques and perioperative management have varying effects on innate and cellular immunity, the enhancement of adrenergic-inflammatory responses, and the activation of cancer-promoting cellular signaling pathways, which may be associated with long-term cancer outcomes. This review outlines the current knowledge of anesthesia implications on TNF-α release and provides potential anesthetic strategies for improving patient survival. ABSTRACT: Cancer remains a major public health issue and a leading cause of death worldwide. Despite advancements in chemotherapy, radiation therapy, and immunotherapy, surgery is the mainstay of cancer treatment for solid tumors. However, tumor cells are known to disseminate into the vascular and lymphatic systems during surgical manipulation. Additionally, surgery-induced stress responses can produce an immunosuppressive environment that is favorable for cancer relapse. Up to 90% of cancer-related deaths are the result of metastatic disease after surgical resection. Emerging evidence shows that the interactions between tumor cells and the tumor microenvironment (TME) not only play decisive roles in tumor initiation, progression, and metastasis but also have profound effects on therapeutic efficacy. Tumor necrosis factor alpha (TNF-α), a pleiotropic cytokine contributing to both physiological and pathological processes, is one of the main mediators of inflammation-associated carcinogenesis in the TME. Because TNF-α signaling may modulate the course of cancer, it can be therapeutically targeted to ameliorate clinical outcomes. As the incidence of cancer continues to grow, approximately 80% of cancer patients require anesthesia during cancer care for diagnostic, therapeutic, or palliative procedures, and over 60% of cancer patients receive anesthesia for primary surgical resection. Numerous studies have demonstrated that perioperative management, including surgical manipulation, anesthetics/analgesics, and other supportive care, may alter the TME and cancer progression by affecting inflammatory or immune responses during cancer surgery, but the literature about the impact of anesthesia on the TNF-α production and cancer progression is limited. Therefore, this review summarizes the current knowledge of the implications of anesthesia on cancers from the insights of TNF-α release and provides future anesthetic strategies for improving oncological survival. MDPI 2023-01-25 /pmc/articles/PMC9913216/ /pubmed/36765695 http://dx.doi.org/10.3390/cancers15030739 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tseng, Wei-Cheng
Lai, Hou-Chuan
Huang, Yi-Hsuan
Chan, Shun-Ming
Wu, Zhi-Fu
Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
title Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
title_full Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
title_fullStr Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
title_full_unstemmed Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
title_short Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
title_sort tumor necrosis factor alpha: implications of anesthesia on cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913216/
https://www.ncbi.nlm.nih.gov/pubmed/36765695
http://dx.doi.org/10.3390/cancers15030739
work_keys_str_mv AT tsengweicheng tumornecrosisfactoralphaimplicationsofanesthesiaoncancers
AT laihouchuan tumornecrosisfactoralphaimplicationsofanesthesiaoncancers
AT huangyihsuan tumornecrosisfactoralphaimplicationsofanesthesiaoncancers
AT chanshunming tumornecrosisfactoralphaimplicationsofanesthesiaoncancers
AT wuzhifu tumornecrosisfactoralphaimplicationsofanesthesiaoncancers